The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

New England Journal of Medicine

Volumn 329, Issue 20, 1993, Pages 1456-1462

  Lewis, Edmund J ^a   Hunsicker, Lawrence G ^b   Bain, Raymond P ^c   Rohde, Richard d ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CAPTOPRIL; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADULT; CAPTOPRIL; CREATININE; DIABETIC NEPHROPATHIES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMAN; KIDNEY; MALE; MIDDLE AGE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027517659     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199311113292004     Document Type: Article

References (34)

1. Mogensen CE Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 1976; 36: 383-388
2. Christlieb AR, Warram JH, Krolewski AS, Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes 1981; 30: Suppl 2: 90-96
3. Mogensen CE Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 1982; 285: 685-688
4. Parving H-H, Andersen AR, Smidt UM, Svendsen PA Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983; 1: 1175-1179
5. Parving H-H, Andersen AR, Hommel E, Smidt U Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension 1985; 7: Suppl II: II-114
6. Hommel E, Parving H-H, Mathiesen E, Edsberg B, Damkjaer Nielsen M, Giese J Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. BMJ 1986; 293: 467-470
7. Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. BMJ 1986; 293: 471-474
8. Parving H-H, Hommel E, Smidt UM Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 1988; 297: 1086-1091
9. Zatz R, Meyer TW, Rennke HG, Brenner BM Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 1985; 82: 5963-5967
10. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925-1930
11. Anderson S, Rennke HG, Garcia DL, Brenner BM Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 1989; 36: 526-536
12. Bain R, Rohde R, Hunsicker LG, A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. J Am Soc Nephrol 1992; 3: Suppl: S97-S103
13. Wei LJ, Lachin JM Properties of the urn randomization in clinical trials. Control Clin Trials 1988; 9: 345-364 [Erratum, Controlled Clin Trials 1989;10:126.]
14. SAS user's guide: statistics, version 5 ed. Cary, N.C.: SAS Institute, 1985.
15. Mehta C, Patel N. StatXact: statistical software for exact nonparametric inference: user manual, version 2. Cambridge, Mass.: Cytel Software, 1991.
16. Cox DR. The analysis of binary data. London: Methuen, 1970.
17. Lehmann EL, D'Abrera HJM. Nonparametrics: statistical methods based on ranks. San Francisco: Holden-Day, 1975.
18. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames: Iowa State University Press, 1980.
19. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.
20. Lin DY Goodness-of-fit analysis for the Cox regression model based on a class of parameter estimators. J Am Stat Assoc 1991; 86: 725-728
21. Laird NM, Ware JH Random-effects models for longitudinal data. Biometrics 1982; 38: 963-974
22. Wei LJ, Lachin JM Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Am Stat Assoc 1984; 79: 653-661
23. Lan KKG, DeMets DL Discrete sequential boundaries for clinical trials. Biometrika 1993; 70: 659-663
24. Berk BC, Vekshtein V, Gordon HM, Tsuda T Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989; 13: 305-314
25. Fogo A, Yoshida Y, Yared A, Ichikawa I Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys. Kidney Int 1990; 38: 1068-1074
26. Fogo A, Ichikawa I Evidence for the central role of glomerular growth promoters in the development of sclerosis. Semin Nephrol 1989; 9: 329-342
27. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990; 85: 541-549
28. Parving H-H, Hommel E, Damkjaer Nielsen M, Giese J Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. BMJ 1989; 299: 533-536
29. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988; 297: 1092-1095
30. Mathiesen ER, Hommel E, Giese J, Parving H-H Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 1991; 303: 81-87
31. Taguma Y, Kitamoto Y, Futaki G, Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 1985; 313: 1617-1620
32. Praga M, Hernandez E, Montoyo C, Andres A, Ruilope LM, Rodicio JL Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1992; 20: 240-248
33. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993; 118: 129-138
34. Remuzzi G, Bertani T Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990; 38: 384-394